E Merck's float raises $1.4 billion:
This article was originally published in Clinica
E Merck, the German pharmaceutical and laboratory supplies company, has raised DM 2,100 million ($1,400 million) from the largest ever public share offering in Germany. In the five-times subscribed offer, E Merck sold 40 million shares, 25% of its enlarged capital, at a price of DM 54 each. This was close to the top of the range of DM 46-56 indicated for the book building process which preceded the float. The shares started trading on the Frankfurt and Zurich stock exchanges on October 20th.
You may also be interested in...
Cilta-cel maintained high response rates in longer-term multiple myeloma data, but ide-cel causes less cytokine release syndrome and severe neurotoxicity – and it has a March decision date at the US FDA.
Our updated graphic tracker of key developments from the leading vaccine candidates.
Pathway open for drug as post-covalent BTK option as Loxo gears up for "risky" Phase III head-to-head study in Q1 2021.